About Cholestech
Cholestech is a Healthcare company based in San Diego (United States) founded in 1988, and was acquired by Abbott in June 2007. Point-of-care diagnostics solutions for chronic diseases. Cholestech has raised $24 million across 1 funding round from investors including Abbott Global Point of Care. Cholestech has completed 1 acquisition, including Health Net. Its focus areas include Diversified Diagnostics.
Company details
Cholestech developed point-of-care diagnostics solutions for chronic diseases. Its flagship product Cholestech LDX (R) measures cholesterol, glucose, liver enzymes and C-reactive Protein to identify high-risk heart disease patients. Another product Cholestech GDX was an at-home device for measurement of average blood glucose or A1C levels. In June 2007, Alere (then known as Inverness Medical) acquired the company for 326.3M. Cholestech was an inaugural member of the NASDAQ Healthcare Index.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Website cholestech.com
- Social LinkedIn
- Acquired by Abbott (Jun 2007)
- Total Equity Funding$24M (USD)
in 1 rounds
- Latest Funding Round$24M (USD), Series B
Feb 1991
- Investors
- Investments & Acquisitions
- Acquired byAbbott
(Jun 2007)
Funding Insights of Cholestech
Cholestech has successfully raised a total of $24M through 1 strategic funding round. The most recent funding activity was a Series B round of $24 million completed in February 1991. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $24M
- Total Rounds 1
- Last Round Series B — $24M
- First Round $24M
(Feb 1991)
All 1 funding rounds of Cholestech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 1991 | $24M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in Cholestech
Cholestech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott Global Point of Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Rapid diagnostics products and solutions for point-of-care testing are provided. | 1900 | globalpointofcare.abbott | Waukegan, United States |
Investor details for Cholestech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cholestech
8 people are tracked at Cholestech (1 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Dominic Chan | Director Of Engineering | Leadership |
Aaron Hou | Process Engineer III | Team |
Tisha Williams | Quality Control Tech. | Team |
Harish Raj | Sr Process Specialist | Team |
Genise Grigsby | Electronic Assembler | Team |
Linda Crow | Executive Assistant | Team |
Antoniette Salvatin | QC Analyst 2 | Team |
Dylan Nguyen | Process Engineering Chemist | Team |
Complete people profiles for Cholestech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cholestech
Cholestech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Health Net.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Health plans and services are provided to individuals and businesses. | healthnet.com | Los Angeles, United States | 1977 | Jan 2000 | $3M |
Complete acquisition details for Cholestech
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cholestech
4 dated milestones of Cholestech across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Cholestech is founded.
- Funding First funding round of $24.0M.
- Acquisition Acquires Health Net.
- Exit Acquired by Abbott.
Web traffic of Cholestech
Websites that share an audience with Cholestech (cholestech.com).
Websites whose visitors overlap most with Cholestech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dianon.com | 100% | View details | |||
| diasorin.com | 100% | 76.8K | #434,252 | View details | |
| optimaeye.com | 100% | #3,245,484 | View details | ||
| cspmedical.com | 100% | #5,515,629 | View details | ||
| meridianbioscience.com | 100% | 31.9K | #999,696 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 23 similar websites and full traffic analytics for Cholestech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 23 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
3 companies that operate in the same segment as Cholestech (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | 336 | ||
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | |||
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | USD 4.45 M | 54 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cholestech
Complete news archive for Cholestech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cholestech
Cholestech was founded in 1988 and raised its 1st funding round 3 years after it was founded.
Cholestech is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Cholestech is a funded company, having raised a total of $24M across 1 funding round to date. The company's 1st funding round was a Series B of $24M, raised on Feb 1991.
Cholestech developed point-of-care diagnostics solutions for chronic diseases. Its flagship product Cholestech LDX (R) measures cholesterol, glucose, liver enzymes and C-reactive Protein to identify high-risk heart disease patients. Another product Cholestech GDX was an at-home device for measurement of average blood glucose or A1C levels. In June 2007, Alere (then known as Inverness Medical) acquired the company for 326.3M. Cholestech was an inaugural member of the NASDAQ Healthcare Index.
Cholestech has made 1 acquisition, including Health Net.
Cholestech has 1 investor. Key investors include Abbott Global Point of Care.
Yes. Cholestech was acquired by Abbott in June 2007.